Virus News and Research

Latest Virus News and Research

Nanobody inhalation found to be effective against COVID-19 in hamsters

In a recent paper, researchers describe an aerosolized nanobody formulation that was found to effectively block SARS-CoV-2 in Syrian hamsters.

27 May 2021

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases

Waters Corporation today introduced a new RUO LC-MS test method to advance critical infectious disease research.

From Waters Corporation 27 May 2021

New DNA COVID-19 vaccine proven effective in mice

A new study has shown that a new DNA-based COVID-19 vaccine successfully induced immunization against SARS-CoV-2 in mice and hamsters.

27 May 2021

Study shows CoronaVac to have high seroconversion rate after 40 days

Researchers from the Federal University of Paraná, Brazil, looked into the seroconversion rate after vaccination with the CoronaVac. Using immunoassays, they measured the immunoglobulins (IgG) for anti-nucleocapsid protein (anti-N) antibodies and anti-spike-1 (anti-S1) protein antibodies.

27 May 2021

Protein-RNA interactions in SARS-CoV-2-infected cells reveal key regulators of infection

Researchers in the UK, including the University of Oxford and Glasgow, as well as the University of Heidelberg, published their analysis of protein-RNA interactions in SARS-CoV-2 and the subsequent significance in the journal Molecular Cell. This research could help to uncover novel antiviral strategies for COVID-19 due to a broader understanding of how the virus works.

27 May 2021

Study details challenges and progress toward creating a COVID-19 drug

The COVID-19 pandemic has seen scientists perform incredible feats in a short amount of time, from developing tests to new types of vaccines.

26 May 2021

Astodrimer sodium exhibits potent virucidal and antiviral activity against SARS-CoV-2 in vitro

Researchers from the US and Australia recently conducted some studies to assess the in vitro antiviral and virucidal (irreversible) activity of astodrimer sodium against SARS-CoV-2.

26 May 2021

Neurocognitive symptoms persist 6 months post-infection with long COVID

According to the World Health Organization (WHO), COVID-19 long-haulers are people who experience symptoms such as body ache, fatigue, shortness of breath, headache, difficulty concentrating, loss of taste or smell, or other health issues long after they test negative for the virus. It can be defined as having serious and prolonged symptoms three months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

26 May 2021

Reducing COVID-19 burden with monoclonal antibodies and vaccination

Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress the transmission of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and reduce the burden of coronavirus disease 2019 (COVID-19) more than vaccination alone.

26 May 2021

Will SARS-CoV-2 eventually become just another seasonal coronavirus?

Could SARS-CoV-2 become just a seasonal nuisance in the next decade, causing just coughs and sniffles like a common cold, suggests new research? Scientists at the University of Utah, USA, tried to predict the possible future of the novel coronavirus using mathematical models that use learnings from the current pandemic on changes in human immunity over time.

26 May 2021

Can certain aircraft boarding procedures increase SARS-CoV-2 transmission risks?

In a study published in the Royal Society Open Science journal, researchers simulated many aircraft boarding processes to assess their impact on social proximity during boarding. They also studied the dominant mechanisms by which these processes generate social proximity. The researchers systematically measured proximity by measuring the number of contacts originating from the following situations: 1. contacts between seated passenger pairs; 2. contacts between aisle passenger pairs; and 3. contacts between a seated passenger and an aisle passenger.

26 May 2021

CASdetec: new CRISPR-based SARS-CoV-2 detection platform detects nucleic acids with high sensitivity and specificity

To add to existing CRISPR-based nucleic acid detection protocols, a team of researchers recently established a new SARS-CoV-2 detection protocol based on their previously reported platform - CDetection (Cas12b-mediated DNA detection). They combined nucleic-acid amplification methods and sample treatment protocols with CDetection and established an integrated nucleic acid detection platform called CRISPR-assisted detection or CASdetec. CASdetec has a detection limit of 1×104 copies/mL for SARS-CoV-2 pseudovirus, without any observed cross-reactivity.

26 May 2021

New COVID-19 test can deliver highly accurate results in less than 15 minutes

A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.

26 May 2021

Researchers develop a method to detect SARS-CoV-2 and variants simultaneously

Researchers demonstrate a method of detecting the presence and mutations in the SARS-CoV-2 virus using the smaller and cheaper Oxford Nanopore sequencer, a method they believe could make pandemic surveillance faster and cheaper.

26 May 2021

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

26 May 2021

New SARS-CoV-2 variants emerge among children in United States, suggests study

As the coronavirus disease 2019 (COVID-19) pandemic approaches its eighteenth month, new variants of concern (VOCs) of the causative pathogen – severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – continue to emerge all over the world. A new study explores the emergence of such VOCs among young children, below 12 years of age, and the potential consequences of this phenomenon.

26 May 2021

‘Better than the hospital’: Pandemic boosts care for serious illnesses at home

Late last year, Janet Yetenekian was one of the thousands of people in Southern California whose case of covid-19 was serious enough to send her to the hospital.

26 May 2021

Tissue-resident memory T cells found in lungs of people who had COVID-19 10 months ago

In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.

26 May 2021

Italian HCW study reaffirms Pfizer-BioNTech effectiveness against COVID-19

Real-world data from Pasquale Stefanizzi of Aldo Moro University in Italy and colleagues confirm that the Pfizer-BioNTech vaccine effectively prevents COVID-19 infection.

26 May 2021

Zoonotic and vector-borne emerging tropical diseases pose a constant threat

A recent article published in the journal Frontiers in Tropical Diseases assessed the threat of emerging zoonotic and vector-borne tropical diseases.

26 May 2021

Virus News and Research

Latest Virus News and Research

Nanobody inhalation found to be effective against COVID-19 in hamsters

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases

New DNA COVID-19 vaccine proven effective in mice

Study shows CoronaVac to have high seroconversion rate after 40 days

Protein-RNA interactions in SARS-CoV-2-infected cells reveal key regulators of infection

Study details challenges and progress toward creating a COVID-19 drug

Astodrimer sodium exhibits potent virucidal and antiviral activity against SARS-CoV-2 in vitro

Neurocognitive symptoms persist 6 months post-infection with long COVID

Reducing COVID-19 burden with monoclonal antibodies and vaccination

Will SARS-CoV-2 eventually become just another seasonal coronavirus?

Can certain aircraft boarding procedures increase SARS-CoV-2 transmission risks?

CASdetec: new CRISPR-based SARS-CoV-2 detection platform detects nucleic acids with high sensitivity and specificity

New COVID-19 test can deliver highly accurate results in less than 15 minutes

Researchers develop a method to detect SARS-CoV-2 and variants simultaneously

Could GRP78 be a therapeutic target against COVID-19?

New SARS-CoV-2 variants emerge among children in United States, suggests study

‘Better than the hospital’: Pandemic boosts care for serious illnesses at home

Tissue-resident memory T cells found in lungs of people who had COVID-19 10 months ago

Italian HCW study reaffirms Pfizer-BioNTech effectiveness against COVID-19

Zoonotic and vector-borne emerging tropical diseases pose a constant threat

A new way of characterising biomolecules eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in